PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 1 filers reported holding PORTOLA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $35,000 | +150.0% | 1,970 | -1.0% | 0.00% | +100.0% |
Q1 2020 | $14,000 | -70.8% | 1,990 | 0.0% | 0.00% | -50.0% |
Q4 2019 | $48,000 | -9.4% | 1,990 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $53,000 | -1.9% | 1,990 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $54,000 | -21.7% | 1,990 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $69,000 | -53.4% | 1,990 | -73.8% | 0.00% | -60.0% |
Q4 2018 | $148,000 | -31.5% | 7,590 | -6.3% | 0.01% | -16.7% |
Q3 2018 | $216,000 | +6.9% | 8,100 | +51.1% | 0.01% | 0.0% |
Q2 2018 | $202,000 | +15.4% | 5,360 | 0.0% | 0.01% | 0.0% |
Q1 2018 | $175,000 | -62.0% | 5,360 | -43.3% | 0.01% | -57.1% |
Q4 2017 | $461,000 | -9.8% | 9,460 | 0.0% | 0.01% | -17.6% |
Q3 2017 | $511,000 | -3.8% | 9,460 | 0.0% | 0.02% | +6.2% |
Q2 2017 | $531,000 | +43.1% | 9,460 | 0.0% | 0.02% | +45.5% |
Q1 2017 | $371,000 | +68.6% | 9,460 | -2.2% | 0.01% | +83.3% |
Q3 2016 | $220,000 | -3.5% | 9,670 | 0.0% | 0.01% | -14.3% |
Q2 2016 | $228,000 | +13.4% | 9,670 | -2.0% | 0.01% | +16.7% |
Q1 2016 | $201,000 | -60.7% | 9,870 | -0.7% | 0.01% | -60.0% |
Q4 2015 | $511,000 | -64.4% | 9,940 | -79.8% | 0.02% | -71.7% |
Q2 2014 | $1,435,000 | – | 49,170 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fernwood Investment Management, LLC | 228,873 | $7,475,000 | 4.17% |
PFM Health Sciences, LP | 5,326,671 | $173,969,000 | 3.54% |
Marcus Capital, LLC | 22,950 | $750,000 | 2.76% |
Partner Investment Management, L.P. | 72,284 | $2,361,000 | 2.55% |
CADIAN CAPITAL MANAGEMENT, LP | 1,240,944 | $40,529,000 | 2.19% |
HARVEY CAPITAL MANAGEMENT INC | 158,580 | $5,179,000 | 1.94% |
SECTORAL ASSET MANAGEMENT INC | 498,412 | $16,278,000 | 1.78% |
Everett Capital Advisors UK LLP | 551,173 | $18,001,000 | 1.52% |
ROSENBLUM SILVERMAN SUTTON S F INC /CA | 125,210 | $4,089,000 | 1.46% |
Atika Capital Management LLC | 113,000 | $3,691,000 | 1.26% |